Notice for Retifanlimab (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
Retifanlimab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
sterile aqueous solution for intravenous infusion
Indication
For the treatment of Merkel Cell Carcinoma
Therapeutic area
Oncology